XML 25 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 28, 2025
Dec. 29, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 15,124 $ 15,455 $ 15,444
Cost of sales 6,332 6,496 6,801
Gross profit 8,792 8,959 8,643
Selling, general, and administrative expenses 6,088 6,329 6,141
Restructuring expenses 290 185 0
Impairment charges 23 578 0
Other operating (income) expense, net (23) 26 (10)
Operating income 2,414 1,841 2,512
Other expense, net 36 48 72
Interest expense, net 379 378 250
Income before taxes 1,999 1,415 2,190
Provision for taxes 529 385 526
Net income $ 1,470 $ 1,030 $ 1,664 [1]
Net income per share      
Basic (in dollars per share) $ 0.77 $ 0.54 $ 0.90
Diluted (in dollars per share) $ 0.76 $ 0.54 $ 0.90
Weighted-average number of shares outstanding      
Basic (in shares) 1,917 1,915 1,846
Diluted (in shares) 1,924 1,923 1,850
[1] Prior to April 4, 2023, the Company operated as a segment of J&J and not as a separate entity. The Company’s financial statements prior to April 4, 2023 were prepared on a combined basis and were derived from J&J’s historical consolidated financial statements and accounting records as if the Company had been operated on a standalone basis. See Note 1, “Description of the Company and Summary of Significant Accounting Policies—Basis of Presentation,” for more information.